# Thermo Fisher Scientific Inc. (TMO) — Q4-2021 Earnings Results

**Report date:** 2022-02-02 (before market open)  
**Sector:** Health Care / Life Sciences Tools & Services  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/TMO/earnings/Q4-2021

## Post-Earnings Brief

### Headline

Thermo Fisher Scientific Beats on EPS, Stock Up 1.65%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $6.54 | N/A | +25.29% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their ability to navigate current challenges. They are optimistic about future growth opportunities despite some uncertainties.

**Key quotes:**

> Management highlighted strong demand for their products.

> They noted ongoing challenges in the supply chain but remain focused on growth.

> The team emphasized their commitment to innovation and customer service.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Thermo Fisher Scientific's strong EPS performance indicates better-than-expected profitability, which likely contributed to the stock's 1.65% increase. The lack of revenue data and guidance may leave some investors cautious, but management's positive outlook on demand and innovation suggests potential for continued growth. Overall, the earnings report reflects resilience in a challenging environment.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/TMO/earnings/Q4-2021_